<doc>
  <docmeta id="113hr4709eh">
    <bill congress="113" type="hr" number="4709" version="eh"/>
    <revision size="6984" annotations="0" status="complete" id="6" commit-time="2014-08-05T22:56:34Z" committer="mbohmer" doc="113hr4709eh/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Engrossed-in-House" bill-type="olc" dms-id="HEA367D0501F54DFE8B821C161D1C78A9" public-private="public" stage-count="1"> 
<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4709 EH: Ensuring Patient Access and Effective Drug Enforcement Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/"/>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="no">I</distribution-code> 
<congress>113th CONGRESS</congress> <session>2d Session</session> 
<legis-num>H. R. 4709</legis-num> 
<current-chamber display="no">IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<legis-type>AN ACT</legis-type> 
<official-title display="yes">To improve enforcement efforts related to prescription drug diversion and abuse, and for other purposes.</official-title> 
</form> 
<legis-body id="HAEF97E493D1940C693F84A1B5D02C1F7" style="OLC"> 
<section id="H71FB06D9A0A94926B887E5BE1E538C12" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Ensuring Patient Access and Effective Drug Enforcement Act of 2014" proposed="true">Ensuring Patient Access and Effective Drug Enforcement Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
    </section> 
<section id="HCE607419F1D34D6EB8A11EC312ECD226">
      <enum>2.</enum>
      <header>Registration process under Controlled Substances Act</header> 
<subsection id="H5306A535106842CEA7168B562BABAC6E">
        <enum>(a)</enum>
        <header>Definitions</header> 
<paragraph id="H22FA1DC728154998BCE7EE52F234919D">
          <enum>(1)</enum>
          <header>Factors as may be relevant to and consistent with the public health and safety</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303">Section 303 of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
              <cato:entity-ref entity-type="uscode" value="usc/21/823">21 U.S.C. 823</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="H363843CE43714E49AB156F60AAB21DB1" style="OLC"> 
<subsection id="HC569CBA06D4C441EBBFAD425B60CF527">
              <enum>(i)</enum>
              <text display-inline="yes-display-inline">In this section, the phrase <quote>factors as may be relevant to and consistent with the public health and safety</quote> means factors that are relevant to and consistent with the findings contained in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:101">section 101</cato:entity-ref>.</text>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
        </paragraph> 
<paragraph id="H900618BBCC944BB8BCC639DC372E5130">
          <enum>(2)</enum>
          <header>Imminent danger to the public health or safety</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:304/ss:d">Section 304(d) of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/824">
              <cato:entity-ref entity-type="uscode" value="usc/21/824/d">21 U.S.C. 824(d)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text> 
<subparagraph id="HEFBB9A0247584D26BEC2EB0DCCD49C04">
            <enum>(A)</enum>
            <text>by striking <quote>(d) The Attorney General
              </quote> and inserting <quote>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:304/ss:d/p:1" proposed="true">(d)(1)</cato:entity-ref> The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref>
              </quote>; and</text>
          </subparagraph> 
<subparagraph id="H4138CA7EE7C94012821D34183B7874E5">
            <enum>(B)</enum>
            <text>by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="HDEF025DDA7BA4A52B7C7F6B6761B987D" style="OLC"> 
<paragraph id="H7C924D2D4300454084F72F687BDFFECE" indent="up1">
                <enum>(2)</enum>
                <text display-inline="yes-display-inline">In this subsection, the phrase <term>imminent danger to the public health or safety</term> means that, in the absence of an immediate suspension order, controlled substances—</text> 
<subparagraph id="H45E8BDFF0DE14BEB83E02C0F6891DB51">
                  <enum>(A)</enum>
                  <text>will continue to be intentionally distributed or dispensed—</text> 
<clause id="H1933648CFE944D5894A5B487CDF1D4CB">
                    <enum>(i)</enum>
                    <text display-inline="yes-display-inline">outside the usual course of professional practice; or</text>
                  </clause> 
<clause id="HCF562A9AA6B149ACB1D1F95A9ED5A77F">
                    <enum>(ii)</enum>
                    <text>in a manner that poses a present or foreseeable risk of serious adverse health consequences or death; or</text>
                  </clause>
                </subparagraph> 
<subparagraph id="HED94D6D1A1C14007A40275E037425DE7">
                  <enum>(B)</enum>
                  <text>will continue to be intentionally diverted outside of legitimate distribution channels.</text>
                </subparagraph>
              </paragraph>
              <after-quoted-block>.</after-quoted-block>
            </quoted-block>
          </subparagraph>
        </paragraph>
      </subsection> 
<subsection id="H919D5C29D791499D832B0BC019DE76A9">
        <enum>(b)</enum>
        <header>Opportunity To submit corrective action plan prior to revocation or suspension</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:304/ss:c">Subsection (c) of section 304 of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/824">
            <cato:entity-ref entity-type="uscode" value="usc/21/824">21 U.S.C. 824</cato:entity-ref>
          </external-xref>)</cato:entity> is amended—</text> 
<paragraph id="HF86ED9E88D30482C87DB31431C217892">
          <enum>(1)</enum>
          <text>by striking the last two sentences in such subsection;</text>
        </paragraph> 
<paragraph id="H01F77CA56680471B96B9E7936C123503">
          <enum>(2)</enum>
          <text>by striking <quote>(c) Before</quote> and inserting <quote>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:304/ss:c/p:1" proposed="true">(c)(1)</cato:entity-ref> Before</quote>; and</text>
        </paragraph> 
<paragraph id="H96F65A1C309343CEB8A271E50783F677">
          <enum>(3)</enum>
          <text>by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="H14A81C371A124B00B74C1BB759D2A90F" style="OLC"> 
<paragraph id="H818C725CA32941F5AE4C7B4FF743064F" indent="up1">
              <enum>(2)</enum>
              <text>An order to show cause under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:304/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall—</text> 
<subparagraph id="H7DC04F26446D43BBA5C365797A994BA4">
                <enum>(A)</enum>
                <text>contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated by the applicant or registrant;</text>
              </subparagraph> 
<subparagraph id="H58F9BAD54DF947388CBCFC0074A7E79F">
                <enum>(B)</enum>
                <text>direct the applicant or registrant to appear before the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref> at a time and place stated in the order, but no less than thirty days after the date of receipt of the order; and</text>
              </subparagraph> 
<subparagraph id="H81EBEE957CBB4B5193ABFB19D42B4A03">
                <enum>(C)</enum>
                <text>notify the applicant or registrant of the opportunity to submit a corrective action plan on or before the date of appearance.</text>
              </subparagraph>
            </paragraph> 
<paragraph id="HDDAEB68EE86C46EF846AD61851444FFE" indent="up1">
              <enum>(3)</enum>
              <text>Upon review of any corrective action plan submitted by an applicant or registrant pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:304/ss:c/p:2" proposed="true">paragraph (2)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref> shall determine whether denial, revocation or suspension proceedings should be discontinued, or deferred for the purposes of modification, amendment, or clarification to such plan.</text>
            </paragraph> 
<paragraph id="HC341FA78C8EC4E3CBB1E42489F7E23F6" indent="up1">
              <enum>(4)</enum>
              <text>Proceedings to deny, revoke, or suspend shall be conducted pursuant to this section in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc-chapter/5/5/II">subchapter II of <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/5/5">chapter 5</external-xref> of title 5</cato:entity-ref>. Such proceedings shall be independent of, and not in lieu of, criminal prosecutions or other proceedings under this title or any other law of the United States.</text>
            </paragraph> 
<paragraph id="H36C826AE1CBE4AFE9602499F09552B68" indent="up1">
              <enum>(5)</enum>
              <text>The requirements of this subsection shall not apply to the issuance of an immediate suspension order under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:304/ss:d">subsection (d)</cato:entity-ref>.</text>
            </paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
        </paragraph>
      </subsection>
    </section> 
<section id="HA72B90AD1F004BD59C5A71765787DF1B">
      <enum>3.</enum>
      <header>Report to Congress on effects of law enforcement activities on patient access to medications</header> 
<subsection id="HFD8E94DA3E174658B6776898F6C155B7">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">Not later than one year after the date of enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Commissioner of Food and Drugs</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, and in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1524" entity-type="federal-body">Administrator of the Drug Enforcement Administration</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1127">Director of National Drug Control Policy</cato:entity-ref>, shall submit a report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HJU00" entity-type="committee">Committees on the Judiciary of the House of Representatives</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HIF00" entity-type="committee">Committee on Energy and Commerce of the House of Representatives</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSJU00" entity-type="committee">Committee on the Judiciary of the Senate</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSHR00" entity-type="committee">Committee on Health, Education, Labor and Pensions of the Senate</cato:entity-ref> identifying—</text> 
<paragraph id="HD2C44B04DD6A410D90EAD7172EA7BEFB">
          <enum>(1)</enum>
          <text>obstacles to legitimate patient access to controlled substances;</text>
        </paragraph> 
<paragraph id="H2BC13C38B23E48C98ADC53AE2A19F530">
          <enum>(2)</enum>
          <text>issues with diversion of controlled substances; and</text>
        </paragraph> 
<paragraph id="H21717A3FD57A44448BD166B441E02C96">
          <enum>(3)</enum>
          <text>how collaboration between Federal, State, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.</text>
        </paragraph>
      </subsection> 
<subsection id="H7DED1A4A89A7442EA504E8EC24DF85E9">
        <enum>(b)</enum>
        <header>Consultation</header>
        <text display-inline="yes-display-inline">The report under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Ensuring Patient Access and Effective Drug Enforcement Act of 2014/s:3/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall incorporate feedback and recommendations from the following:</text> 
<paragraph id="H092E27C086584A9FB8D1B652B975F6FD">
          <enum>(1)</enum>
          <text>Patient groups.</text>
        </paragraph> 
<paragraph id="H5CD65F75C12849BDA6D28D3B4B888192">
          <enum>(2)</enum>
          <text>Pharmacies.</text>
        </paragraph> 
<paragraph id="H9469E001598C4B808B8554CF74A3EAE5">
          <enum>(3)</enum>
          <text>Drug manufacturers.</text>
        </paragraph> 
<paragraph id="H4C1B8E43FFE643FE9E5FAFB80C1C3D6B">
          <enum>(4)</enum>
          <text>Common or contract carriers and warehousemen.</text>
        </paragraph> 
<paragraph id="HECACCE814CF34A90AD1D19D19CAA8931">
          <enum>(5)</enum>
          <text>Hospitals, physicians, and other health care providers.</text>
        </paragraph> 
<paragraph id="HA5BEFFAC62054C27B0C0FFC7FA48F57C">
          <enum>(6)</enum>
          <text>State attorneys general.</text>
        </paragraph> 
<paragraph id="H44FB8066A4584465AEAB20596F6A349C">
          <enum>(7)</enum>
          <text display-inline="yes-display-inline">Federal, State, local, and tribal law enforcement agencies.</text>
        </paragraph> 
<paragraph id="HBF1D70DCC8A34E7098D1B9295EF8D2CF">
          <enum>(8)</enum>
          <text>Health insurance providers and entities that provide pharmacy benefit management services on behalf of a health insurance provider.</text>
        </paragraph> 
<paragraph id="HF98C2C07D6FB4FB9A1007FC08F5C1729">
          <enum>(9)</enum>
          <text>Wholesale drug distributors.</text>
        </paragraph>
      </subsection>
    </section> 
</legis-body> <attestation>
    <attestation-group>
      <attestation-date date="20140729" chamber="House">Passed the House of Representatives July 29, 2014.</attestation-date>
      <attestor display="no">Karen L. Haas,</attestor>
      <role>Clerk.</role>
    </attestation-group>
  </attestation>
<endorsement display="yes"/>
</bill>
</doc>